Beauty Health (SKIN) Set to Announce Quarterly Earnings on Tuesday

Beauty Health (NASDAQ:SKIN - Get Free Report) is scheduled to be announcing its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter. Individual that wish to listen to the company's conference call can do so using this link.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Beauty Health had a negative net margin of 22.86% and a negative return on equity of 4.57%. The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beauty Health Price Performance

SKIN traded down $0.05 during midday trading on Friday, reaching $1.63. 1,122,906 shares of the company's stock were exchanged, compared to its average volume of 1,871,849. The company has a quick ratio of 5.47, a current ratio of 6.49 and a debt-to-equity ratio of 7.96. The business has a 50-day simple moving average of $1.57 and a two-hundred day simple moving average of $1.93. The firm has a market capitalization of $202.15 million, a price-to-earnings ratio of -1.96 and a beta of 0.90. Beauty Health has a one year low of $0.91 and a one year high of $5.17.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Piper Sandler reiterated an "underweight" rating and set a $1.00 price objective (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Stifel Nicolaus cut their price target on shares of Beauty Health from $4.00 to $2.00 and set a "hold" rating for the company in a report on Friday, July 26th. Finally, Canaccord Genuity Group decreased their price objective on shares of Beauty Health from $2.00 to $1.25 and set a "hold" rating on the stock in a research note on Monday, August 12th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $2.46.

Insider Transactions at Beauty Health

In other news, Chairman Brent L. Saunders acquired 40,450 shares of the firm's stock in a transaction on Monday, August 12th. The shares were purchased at an average cost of $1.08 per share, for a total transaction of $43,686.00. Following the transaction, the chairman now owns 5,921,769 shares of the company's stock, valued at approximately $6,395,510.52. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 41.00% of the stock is owned by company insiders.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.